LeMaitre Vascular Yönetim

Yönetim kriter kontrolleri 3/4

LeMaitre Vascular CEO'su George LeMaitre, Jun1992 tarihinde atandı, in görev süresi 32.67 yıldır. in toplam yıllık tazminatı $ 2.22M olup, şirket hissesi ve opsiyonları dahil olmak üzere 26.7% maaş ve 73.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 8.34% ine doğrudan sahiptir ve bu hisseler € 181.31M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 14.8 yıl ve 19.3 yıldır.

Anahtar bilgiler

George LeMaitre

İcra Kurulu Başkanı

US$2.2m

Toplam tazminat

CEO maaş yüzdesi	26.7%
CEO görev süresi	32.7yrs
CEO sahipliği	8.3%
Yönetim ortalama görev süresi	14.8yrs
Yönetim Kurulu ortalama görev süresi	19.3yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

George LeMaitre'un ücretlendirmesi LeMaitre Vascular'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$41m
Jun 30 2024	n/a	n/a	US$38m
Mar 31 2024	n/a	n/a	US$34m
Dec 31 2023	US$2m	US$593k	US$30m
Sep 30 2023	n/a	n/a	US$27m
Jun 30 2023	n/a	n/a	US$25m
Mar 31 2023	n/a	n/a	US$21m
Dec 31 2022	US$2m	US$568k	US$21m
Sep 30 2022	n/a	n/a	US$21m
Jun 30 2022	n/a	n/a	US$22m
Mar 31 2022	n/a	n/a	US$27m
Dec 31 2021	US$2m	US$473k	US$27m
Sep 30 2021	n/a	n/a	US$28m
Jun 30 2021	n/a	n/a	US$29m
Mar 31 2021	n/a	n/a	US$24m
Dec 31 2020	US$1m	US$311k	US$21m
Sep 30 2020	n/a	n/a	US$19m
Jun 30 2020	n/a	n/a	US$16m
Mar 31 2020	n/a	n/a	US$18m
Dec 31 2019	US$1m	US$438k	US$18m
Sep 30 2019	n/a	n/a	US$19m
Jun 30 2019	n/a	n/a	US$18m
Mar 31 2019	n/a	n/a	US$23m
Dec 31 2018	US$1m	US$438k	US$23m

Tazminat ve Piyasa: George 'nin toplam tazminatı ($USD 2.22M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.49M ).

Tazminat ve Kazançlar: George 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

George LeMaitre (59 yo)

32.7yrs

Görev süresi

US$2,220,797

Tazminat

Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
George LeMaitre	Chairman & CEO	32.7yrs	US$2.22m	8.34% € 181.3m
David Roberts	President & Director	17.6yrs	US$1.13m	0.065% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	17.6yrs	US$1.07m	0.040% € 877.5k
Trent Kamke	Senior Vice President of Operations	20.1yrs	US$670.38k	0.0091% € 196.9k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	42.1yrs	US$138.40k	Veri yok
Kimberly Cieslak	Vice President of Marketing	22.1yrs	Veri yok	Veri yok
Daniel Mumford	Senior Director of Human Resources	5.1yrs	Veri yok	Veri yok
Jonathan Ngau	Senior Vice President of Information Technology	less than a year	Veri yok	Veri yok
Maik Helmers	Senior Vice President of Sales – Central Europe	less than a year	Veri yok	Veri yok
Ryan Connelly	Senior Vice President of Advanced Manufacturing Engineering	2.1yrs	Veri yok	Veri yok
Andrew Hodgkinson	Senior Vice President of Clinical	12.1yrs	Veri yok	Veri yok
Stephane Maier	Senior Vice President of EMEA Operations	4.3yrs	Veri yok	Veri yok

14.8yrs

Ortalama Görev Süresi

50.5yo

Ortalama Yaş

Deneyimli Yönetim: LHU 'un yönetim ekibi deneyimli ve deneyimlidir ( 14.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
George LeMaitre	Chairman & CEO	32.7yrs	US$2.22m	8.34% € 181.3m
David Roberts	President & Director	23.8yrs	US$1.13m	0.065% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	8.3yrs	US$1.07m	0.040% € 877.5k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	no data	US$138.40k	Veri yok
Lawrence Jasinski	Independent Director	22.1yrs	US$153.50k	0.019% € 423.8k
Thomas Naslund	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Steven Kagan	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Herbert Dardik	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Alan Dardik	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
William Jordan	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
John O'Connor	Independent Director	16.4yrs	US$163.00k	0.25% € 5.4m
Bridget Ross	Independent Director	4.8yrs	US$144.50k	0.0078% € 169.3k

19.3yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: LHU 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 19.3 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/02/07 01:26
Gün Sonu Hisse Fiyatı	2025/02/07 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

LeMaitre Vascular, Inc. 22 Bu analistlerden 10, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Michael Petusky	Barrington Research Associates, Inc.
Raymond Myers	Benchmark Company
Jan Wald	Benchmark Company

LeMaitre Vascular Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

President & Director recently sold €353k worth of stock

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Chairman & CEO recently sold €2.6m worth of stock

Chairman & CEO recently sold €411k worth of stock

President & Director recently sold €505k worth of stock

Recent updates

LeMaitre Vascular, Inc. to Report Q4, 2024 Results on Feb 27, 2025

Third quarter dividend of US$0.16 announced

Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024

Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023)

LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024

Second quarter 2024 earnings released: EPS: US$0.53 (vs US$0.36 in 2Q 2023)

LeMaitre Vascular, Inc. to Report Q2, 2024 Results on Aug 01, 2024

First quarter dividend of US$0.16 announced

President & Director recently sold €353k worth of stock

First quarter 2024 earnings released: EPS: US$0.44 (vs US$0.27 in 1Q 2023)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024

LeMaitre Vascular, Inc. to Report Q1, 2024 Results on May 02, 2024

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Upcoming dividend of US$0.16 per share

Fourth quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Full year 2023 earnings released: EPS: US$1.36 (vs US$0.94 in FY 2022)

LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces an Equity Buyback for $50 million worth of its shares.

LeMaitre Vascular, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Chairman & CEO recently sold €2.6m worth of stock

Upcoming dividend of US$0.14 per share at 1.1% yield

Third quarter 2023 earnings released: EPS: US$0.34 (vs US$0.25 in 3Q 2022)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on November 30, 2023

Now 20% undervalued after recent price drop

LeMaitre Vascular, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Investor sentiment deteriorates as stock falls 19%

Upcoming dividend of US$0.14 per share at 1.0% yield

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023, Fourth Quarter and Full Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$0.36 (vs US$0.16 in 2Q 2022)

LeMaitre Vascular, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Chairman & CEO recently sold €411k worth of stock

Upcoming dividend of US$0.14 per share at 0.8% yield

President & Director recently sold €505k worth of stock

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2023

First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2022)

Insufficient new directors

Senior Vice President of Operations recently sold €308k worth of stock

Full year 2022 earnings released: EPS: US$0.94 (vs US$1.27 in FY 2021)

LeMaitre Vascular, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Upcoming dividend of US$0.13 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.30 in 3Q 2021)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q3, 2022 Results on Oct 27, 2022

Lemaitre Vascular, Inc. Appoints Martha Shadan as Director

Upcoming dividend of US$0.13 per share

CFO, Treasurer recently sold €146k worth of stock

CFO, Treasurer recently sold €146k worth of stock

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.40 in 2Q 2021)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 8, 2022

LeMaitre Vascular, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Now 21% undervalued

First quarter 2022 earnings released: EPS: US$0.28 (vs US$0.29 in 1Q 2021)

LeMaitre Vascular, Inc. to Report Q1, 2022 Results on Apr 28, 2022

LeMaitre Vascular, Inc., Annual General Meeting, Jun 01, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.11 per share

Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.37 in 3Q 2020)

Upcoming dividend of US$0.11 per share

Second quarter 2021 earnings released: EPS US$0.40 (vs US$0.17 in 2Q 2020)

LeMaitre Vascular, Inc. has completed a Follow-on Equity Offering in the amount of $54.5 million.

LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Value Index